N/A
N=48
Total Hip Arthroplasty Outcomes With Regional and Multimodal Analgesia
Arthroplasty · Replacement, Hip · Arthritis
Bottom Line
View on ClinicalTrials.gov: NCT02186795 ↗Enrolled (actual)
48
Serious AEs
0.0%
Results posted
Mar 2019
Primary outcome: Primary: Opiate Consumption — 48.6; 53.9 IV MME
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Medical University of South Carolina
- Primary completion
- Mar 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Opiate Consumption |
48.6; 53.9 | — |
Summary
The goal of this retrospective chart review is to evaluate if the implementation of lumbar plexus block placement for postoperative pain and administration of multimodal oral analgesia have improved conditions in the postoperative period for patients undergoing total hip arthroplasty when compared to the placement of epidurals for postoperative pain management.
Eligibility Criteria
Inclusion Criteria
- Primary total hip arthroplasty, (identified by current procedural terminology (CPT) code 27130) and
- Either a) Epidural or b) Lumbar plexus peripheral nerve block with the administration of multimodal medication after July 2012.
-
Exclusion Criteria:Exclusion criteria include THA Revision, ICU admission postoperatively, and dementia, not allowing pain score communication.
-
Data sourced from ClinicalTrials.gov (NCT02186795). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.